e-learning
resources
ERJ
2005
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Epidemiology of Pseudomonas aeruginosa in a cystic fibrosis rehabilitation centre
Van daele S. G., Franckx H., Verhelst R., Schelstraete P., Haerynck F., Van Simaey L., Claeys G., Vaneechoutte M., de Baets F.
Source:
Eur Respir J 2005; 25: 474-481
Journal Issue:
March
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Van daele S. G., Franckx H., Verhelst R., Schelstraete P., Haerynck F., Van Simaey L., Claeys G., Vaneechoutte M., de Baets F.. Epidemiology of Pseudomonas aeruginosa in a cystic fibrosis rehabilitation centre. Eur Respir J 2005; 25: 474-481
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
To code or not to code chronic pulmonary aspergillosis associated malnutrition in PMSI database: that is the problem…
Cystic fibrosis and intestinal organoids
Related content which might interest you:
Factors associated with infection by Pseudomonas aeruginosa in adult cystic fibrosis
Source: Eur Respir J 2005; 26: 651-656
Year: 2005
Evaluating the Leeds criteria for Pseudomonas aeruginosa infection in a cystic fibrosis centre
Source: Eur Respir J 2006; 27: 937-943
Year: 2006
Survey of Pseudomonas aeruginosa genotypes in colonised cystic fibrosis patients
Source: Eur Respir J 2006 Oct 01;28(4):740-747
Year: 2006
Eradication of Pseudomonas aeruginosa in cystic fibrosis
Source: Eur Respir J 2006; 27: 438-439
Year: 2006
Pseudomonas aeruginosa in the home environment of newly infected cystic fibrosis patients
Source: Eur Respir J 2008; 31: 822-829
Year: 2008
Eradication of Pseudomonas aeruginosa in cystic fibrosis patients
Source: Eur Respir J 2006; 27: 653
Year: 2006
Inflammatory markers in cystic fibrosis patients with transmissible Pseudomonas aeruginosa
Source: Eur Respir J 2003; 22: 503-506
Year: 2003
Pseudomonas aeruginosa transmission is infrequent in New Zealand cystic fibrosis clinics
Source: Eur Respir J 2008; 32: 1583-1590
Year: 2008
Increased airway iron as a potential factor in the persistence of Pseudomonas aeruginosa infection in cystic fibrosis
Source: Eur Respir J 2007; 30: 286-292
Year: 2007
Antibodies against Pseudomonas aeruginosa in patients with cystic fibrosis – clinical application
Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research
Year: 2018
Sputum versus bronchoscopy for diagnosis of Pseudomonas aeruginosa biofilms in cystic fibrosis
Source: Eur Respir J 2004; 24 : 631-637
Year: 2004
Epidemiology and natural history of
Pseudomonas aeruginosa
airway infections in non-cystic fibrosis bronchiectasis
Source: ERJ Open Res, 4 (2) 00162-2017; 10.1183/23120541.00162-2017
Year: 2018
Cystic fibrosis infection with clonal strains of Pseudomonas aeruginosa: current knowledge and future management
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=105
Year: 2006
Pseudomonas aeruginosa from CF airways uses various strategies to outcompete staphylococcus aureus
Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring
Year: 2016
Epidemiological-molecular study of colonization by pseudomonas aeruginosa in cystic fibrosis patients
Source: Eur Respir J 2002; 20: Suppl. 38, 379s
Year: 2002
Detection of Pseudomonas aeruginosa infection in cystic fibrosis patients by eNose technology
Source: International Congress 2018 – Latest developments in cystic fibrosis
Year: 2018
Epidemiology of Burkholderia cepacia complex colonisation in cystic fibrosis patients
Source: Eur Respir J 2004; 23: 851-856
Year: 2004
Molecular epidemiological analysis suggests cross-infection with Pseudomonas aeruginosa is rare in non-cystic fibrosis bronchiectasis
Source: Eur Respir J 2014; 43: 900-903
Year: 2014
Omics-based tracking of
Pseudomonas aeruginosa
persistence in “eradicated” cystic fibrosis patients
Source: Eur Respir J, 57 (4) 2000512; 10.1183/13993003.00512-2020
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept